Thomas Looi1,2, Karolina Piorkowska3, Charles Mougenot4, Adam Waspe5,3, Kullervo Hynynen5,6, James Drake5,3. 1. University of Toronto, Toronto, Canada. thomas.looi@sickkids.ca. 2. Hospital for Sick Children, Toronto, Canada. thomas.looi@sickkids.ca. 3. Hospital for Sick Children, Toronto, Canada. 4. University Medical Center Utrecht, Utrecht, Netherlands. 5. University of Toronto, Toronto, Canada. 6. Sunnybrook Research Institute, Toronto, Canada.
Abstract
PURPOSE: Intraventricular hemorrhage (IVH) affects approximately 50% of premature births where 50% further develop post-hemorrhagic ventricular dilation (PHVD). Patients face significant impact to long-term development if PHVD is not managed. Unfortunately, there is no accepted treatment to remove the thrombus caused by IVH. This paper describes an acute and chronic IVH model for use with magnetic resonance-guided focused ultrasound (MRgFUS) thrombolysis. METHODS: A total of 12 pigs (~ 1 month in age) were used in the model (eight acute and four chronic). A pre-operative brain MRI was obtained for ventricular targeting. 1.25 cm3/kg of autologous blood was injected through a burr hole lateral to the midline and anterior of the coronal suture at a rate of 0.6 cm3/min. A craniotomy was performed to simulate a "fontanelle". Post-operative MRI was used to calculate the clot volume. Chronic piglets were recovered, monitored daily with a neurological scoring system (NSS), and MRI scanned for 21 days. RESULTS: The clot injection was well tolerated. The average clot size was 3987 mm3 (median = 4330 mm, standard deviation = 739 mm3). Postmortem examination validated the presence of the clot. In the chronic animals, there was an increase in ventricular volume of 30%. Transient neurological impairment immediately followed clot injection and with onset of hydrocephalus in the chronic animals. CONCLUSIONS: This model establishes a measurable and targetable IVH clot in an MRI-based neonatal porcine model. The progressive post-hemorrhagic ventricular dilation in the chronic model is a potential alterable outcome from MRgFUS thrombolysis.
PURPOSE: Intraventricular hemorrhage (IVH) affects approximately 50% of premature births where 50% further develop post-hemorrhagic ventricular dilation (PHVD). Patients face significant impact to long-term development if PHVD is not managed. Unfortunately, there is no accepted treatment to remove the thrombus caused by IVH. This paper describes an acute and chronic IVH model for use with magnetic resonance-guided focused ultrasound (MRgFUS) thrombolysis. METHODS: A total of 12 pigs (~ 1 month in age) were used in the model (eight acute and four chronic). A pre-operative brain MRI was obtained for ventricular targeting. 1.25 cm3/kg of autologous blood was injected through a burr hole lateral to the midline and anterior of the coronal suture at a rate of 0.6 cm3/min. A craniotomy was performed to simulate a "fontanelle". Post-operative MRI was used to calculate the clot volume. Chronic piglets were recovered, monitored daily with a neurological scoring system (NSS), and MRI scanned for 21 days. RESULTS: The clot injection was well tolerated. The average clot size was 3987 mm3 (median = 4330 mm, standard deviation = 739 mm3). Postmortem examination validated the presence of the clot. In the chronic animals, there was an increase in ventricular volume of 30%. Transient neurological impairment immediately followed clot injection and with onset of hydrocephalus in the chronic animals. CONCLUSIONS: This model establishes a measurable and targetable IVH clot in an MRI-based neonatal porcine model. The progressive post-hemorrhagic ventricular dilation in the chronic model is a potential alterable outcome from MRgFUS thrombolysis.
Authors: Andrew Whitelaw; David Evans; Michael Carter; Marianne Thoresen; Jolanta Wroblewska; Marek Mandera; Janusz Swietlinski; Judith Simpson; Constantinos Hajivassiliou; Linda P Hunt; Ian Pople Journal: Pediatrics Date: 2007-04-02 Impact factor: 7.124
Authors: Tim Lekic; Anatol Manaenko; William Rolland; Paul R Krafft; Regina Peters; Richard E Hartman; Orhan Altay; Jiping Tang; John H Zhang Journal: Exp Neurol Date: 2012-04-15 Impact factor: 5.330
Authors: James P McAllister; Michael R Talcott; Albert M Isaacs; Sarah H Zwick; Maria Garcia-Bonilla; Leandro Castaneyra-Ruiz; Alexis L Hartman; Ryan N Dilger; Stephen A Fleming; Rebecca K Golden; Diego M Morales; Carolyn A Harris; David D Limbrick Journal: Fluids Barriers CNS Date: 2021-11-08
Authors: Marc Melià-Sorolla; Carlos Castaño; Núria DeGregorio-Rocasolano; Luis Rodríguez-Esparragoza; Antoni Dávalos; Octavi Martí-Sistac; Teresa Gasull Journal: Int J Mol Sci Date: 2020-09-08 Impact factor: 5.923